Teachers Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-67,373
Closed -$2.36M 3061
2018
Q1
$2.36M Buy
67,373
+42,519
+171% +$1.49M ﹤0.01% 1725
2017
Q4
$1.06M Buy
24,854
+5,594
+29% +$238K ﹤0.01% 2206
2017
Q3
$826K Buy
19,260
+55
+0.3% +$2.36K ﹤0.01% 2348
2017
Q2
$712K Buy
19,205
+7,558
+65% +$280K ﹤0.01% 2426
2017
Q1
$631K Buy
11,647
+475
+4% +$25.7K ﹤0.01% 2417
2016
Q4
$593K Buy
11,172
+95
+0.9% +$5.04K ﹤0.01% 2446
2016
Q3
$671K Buy
11,077
+81
+0.7% +$4.91K ﹤0.01% 2311
2016
Q2
$724K Buy
10,996
+410
+4% +$27K ﹤0.01% 2217
2016
Q1
$600K Sell
10,586
-17,530
-62% -$994K ﹤0.01% 2243
2015
Q4
$6.61M Buy
28,116
+4,840
+21% +$1.14M 0.01% 1043
2015
Q3
$3.68M Buy
23,276
+67
+0.3% +$10.6K 0.01% 1235
2015
Q2
$8.78M Buy
23,209
+122
+0.5% +$46.2K 0.02% 954
2015
Q1
$9.65M Buy
23,087
+9,161
+66% +$3.83M 0.02% 910
2014
Q4
$3.81M Hold
13,926
0.01% 1251
2014
Q3
$2.71M Buy
13,926
+28
+0.2% +$5.44K 0.01% 1400
2014
Q2
$3.4M Sell
13,898
-248
-2% -$60.7K 0.01% 1300
2014
Q1
$3.75M Buy
14,146
+136
+1% +$36K 0.01% 1234
2013
Q4
$5.09M Buy
14,010
+6,638
+90% +$2.41M 0.01% 1087
2013
Q3
$3.92M Buy
7,372
+240
+3% +$128K 0.01% 1123
2013
Q2
$1.67M Buy
+7,132
New +$1.67M ﹤0.01% 1524